Peptide Purity vs Identity vs Content

A one-line comparison of the three attributes

The shortest useful distinction is this: identity asks what it is, purity asks what else the selected method detects relative to the main response, and content asks how much target material the defined sample or container contains. Each answer depends on a stated analytical procedure and reporting basis.

• Identity: agreement with compound-specific characteristics under a suitable method; commonly qualitative or confirmatory.
• Purity: relative main-component response versus detected and included impurities under defined conditions; commonly reported as a percentage.
• Content or assay: quantity or concentration of target material against a reference and calculation; reported with a mass, concentration, or percentage basis.

Identity asks whether the signal fits the stated material

An identity method compares measured characteristics with those expected for the named compound. LC-MS may compare observed mass-to-charge evidence with an expected molecular form; other strategies may use retention behavior, spectroscopy, amino-acid analysis, or sequence-related evidence. The conclusion should name the technique and the level of identification it supports.

A matching mass or retention time is evidence within that method, not a universal structural guarantee. Closely related species, isomers, salts, adducts, or modifications can require additional discrimination. The EMA synthetic-peptide guideline presents molecular mass, sequence confirmation, composition, counterion identity, and higher-order characteristics as distinct elements that may need different techniques.

Purity asks about components visible to a defined method

In a common HPLC area-percent result, the integrated response assigned to the main peak is divided by the included integrated response. The percentage depends on separation, detector response, wavelength or channel, integration rules, sample preparation, and which peaks are included. It is not a direct inventory of all matter in the vial.

A high chromatographic purity value can coexist with water, counterions, residual solvent, buffer components, or substances that respond differently or are not observed by that detector. It can also require separate identity confirmation for the main peak. Read the purity result with its method and chromatogram rather than turning the percentage into an all-purpose quality score.

Content or assay asks how much target material is present

A content or assay procedure estimates the quantity of the target analyte using a defined sample basis, reference, calibration, response factor, and calculation. Depending on the procedure, the result might be expressed per container, per unit mass, as concentration, or as a percentage of a stated value. The unit and basis are essential parts of the result.

Net content, fill weight, peptide assay, and label claim are not automatically the same field. A gravimetric amount may include non-target components, while an assay can require corrections for water, counterion, or reference-standard potency. ICH Q6A treats identification, assay, and impurities as separate specification elements because each controls a different property.

Build conclusions from orthogonal evidence

Orthogonal methods rely on different measurement principles. HPLC separation with UV detection may characterize relative chromatographic response, while mass spectrometry can add molecular-mass evidence. A suitable quantitative assay can then address target amount. Agreement across these questions creates a more informative evidence set than repeating one type of measurement.

Orthogonal does not mean redundant or automatically sufficient. Each procedure must be fit for its intended purpose, with appropriate specificity, range, accuracy, precision, and other performance characteristics as applicable. ICH Q2(R2) and FDA method-validation guidance organize validation around that intended analytical purpose.

Map each COA field to the question it answers

Read the report row by row. Place identity method and conclusion together; place purity method, integration basis, result, and criterion together; and place assay or content result with its unit, sample basis, reference, and calculation. Supporting tests such as water, counterion, residual solvent, heavy metals, endotoxin, or microbial attributes retain their own scopes.

The MOTS-C family linked below provides an HPLC-centered batch example. The Eloralintide family contains records whose structured fields explicitly name LC-MS and HPLC. Comparing them can demonstrate different field coverage, but it does not establish that the same method, specification, or complete panel applies to every lot. Verify the attached source report before drawing a conclusion.

• Do the product name, presentation, lot, report number, and date match the material record?
• Which row supports identity, and what exact technique is stated?
• Is the purity value an area percentage, an impurity total, or another reporting convention?
• Is content measured separately, and are its unit and sample basis explicit?
• Which attributes are absent, and are they recorded as unreported rather than passed?

Handle missing or conflicting data explicitly

If the certificate provides purity but no identity result, do not infer identity from the largest chromatographic peak. If it provides identity but no content assay, do not infer container quantity from molecular-mass agreement. If the catalog and certificate use different names, strengths, or lots, stop the comparison until the association is resolved.

Preserve qualifiers, units, revisions, and laboratory comments in the review record. Ask for the controlled method or source report when needed. This guide explains analytical language for laboratory documentation; it does not validate any listed batch, establish regulatory status, or support administration to humans or animals.